Treatment delay from onset of occipital neuralgia symptoms to treatment with nerve decompression surgery: a prospective cohort study.

Autor: Hazewinkel, Merel H J, Remy, Katya, Black, Grant, Tseng, Sierra, Mathew, Paul G, Schoenbrunner, Anna, Janis, Jeffrey E, Austen, William G, Jotwani, Rohan, Gfrerer, Lisa
Předmět:
Zdroj: Pain Medicine; May2024, Vol. 25 Issue 5, p334-343, 10p
Abstrakt: Background The aims of this study were to (1) evaluate the time between onset of occipital neuralgia symptoms and nerve decompression surgery, (2) perform a cost comparison analysis between surgical and nonsurgical treatment of occipital neuralgia, and (3) report postoperative results of nerve decompression for occipital neuralgia. Methods Subjects (n  = 1112) who underwent screening for nerve decompression surgery were evaluated for occipital neuralgia. Of those, 367 patients (33%) met the inclusion criteria. Timing of occipital neuralgia symptom onset and pain characteristics were prospectively collected. Cost associated with the nonsurgical treatment of occipital neuralgia was calculated for the period between onset of symptoms and surgery. Results A total of 226 patients (73%) underwent occipital nerve decompression. The average time between onset of occipital neuralgia and surgery was 19 years (7.1–32). Postoperatively, the median number of pain days per month decreased by 17 (0–26, 57%) (P  < .001), the median pain intensity decreased by 4 (2–8, 44%) (P  < .001), and median pain duration in hours was reduced by 12 (2–23, 50%) (P  < .001). The annual mean cost of nonsurgical occipital neuralgia treatment was $28 728.82 ($16 419.42–$41 198.41) per patient. The mean cost during the 19-year time frame before surgery was $545 847.75($311 968.90–$782 769.82). Conclusion This study demonstrates that patients suffer from occipital neuralgia for an average of 19 years before undergoing surgery. Nerve decompression reduces symptom severity significantly and should be considered earlier in the treatment course of occipital neuralgia that is refractory to conservative treatment to prevent patient morbidity and decrease direct and indirect health care costs. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index